Rubicon Organics Inc (ROMJF)
0.25
0.00 (0.00%)
USD |
OTCM |
May 07, 16:00
Rubicon Organics Max Drawdown (5Y): 92.68% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 92.68% |
March 31, 2024 | 92.68% |
February 29, 2024 | 92.68% |
January 31, 2024 | 92.68% |
December 31, 2023 | 92.68% |
November 30, 2023 | 92.68% |
October 31, 2023 | 92.01% |
September 30, 2023 | 91.94% |
August 31, 2023 | 91.94% |
July 31, 2023 | 91.94% |
June 30, 2023 | 91.94% |
May 31, 2023 | 91.30% |
April 30, 2023 | 87.57% |
March 31, 2023 | 87.30% |
February 28, 2023 | 87.30% |
January 31, 2023 | 87.30% |
December 31, 2022 | 87.30% |
November 30, 2022 | 87.30% |
October 31, 2022 | 87.30% |
September 30, 2022 | 87.30% |
August 31, 2022 | 83.73% |
July 31, 2022 | 83.73% |
June 30, 2022 | 83.73% |
May 31, 2022 | 83.73% |
April 30, 2022 | 77.16% |
Date | Value |
---|---|
March 31, 2022 | 73.13% |
February 28, 2022 | 66.72% |
January 31, 2022 | 66.72% |
December 31, 2021 | 61.24% |
November 30, 2021 | 60.00% |
October 31, 2021 | 60.00% |
September 30, 2021 | 60.00% |
August 31, 2021 | 60.00% |
July 31, 2021 | 60.00% |
June 30, 2021 | 60.00% |
May 31, 2021 | 60.00% |
April 30, 2021 | 60.00% |
March 31, 2021 | 60.00% |
February 28, 2021 | 60.00% |
January 31, 2021 | 60.00% |
December 31, 2020 | 60.00% |
November 30, 2020 | 60.00% |
October 31, 2020 | 60.00% |
September 30, 2020 | 60.00% |
August 31, 2020 | 60.00% |
July 31, 2020 | 60.00% |
June 30, 2020 | 60.00% |
May 31, 2020 | 60.00% |
April 30, 2020 | 60.00% |
March 31, 2020 | 60.00% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
34.23%
Minimum
May 2019
92.68%
Maximum
Nov 2023
70.09%
Average
60.00%
Median
Dec 2019
Max Drawdown (5Y) Benchmarks
Acasti Pharma Inc | 98.73% |
Aurinia Pharmaceuticals Inc | 87.58% |
Edesa Biotech Inc | 99.58% |
Lexaria Bioscience Corp | 98.90% |
Xenon Pharmaceuticals Inc | 64.74% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -51.53 |
Beta (5Y) | 1.332 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 59.59% |
Historical Sharpe Ratio (5Y) | -0.6157 |
Historical Sortino (5Y) | -1.159 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 27.80% |